In recent genome-wide association studies, the extracellular chaperone protein, clusterin, has been identified as a newlydiscovered risk factor in Alzheimer's disease. We have examined the interactions between human clusterin and the Alzheimer's disease-associated amyloid-b 1−40 peptide (Ab 1−40 ), which is prone to aggregate into an ensemble of oligomeric intermediates implicated in both the proliferation of amyloid fibrils and in neuronal toxicity. Using highly sensitive single-molecule fluorescence methods, we have found that Ab 1−40 forms a heterogeneous distribution of small oligomers (from dimers to 50-mers), all of which interact with clusterin to form long-lived, stable complexes. Consequently, clusterin is able to influence both the aggregation and disaggregation of Ab 1−40 by sequestration of the Ab oligomers. These results not only elucidate the protective role of clusterin but also provide a molecular basis for the genetic link between clusterin and Alzheimer's disease.
a r t i c l e s
The aggregation of amyloidogenic peptides and proteins is a highly heterogeneous process, as monomers aggregate in a stepwise manner through a series of oligomeric intermediates to form β-sheet-rich fibrillar structures 1, 2 . These oligomers have been implicated not only in the further generation of aggregates but also in the neurotoxicity associated with many neurodegenerative diseases 1, [3] [4] [5] [6] [7] . The detection and characterization of the various oligomeric intermediates and their interactions with other proteins has proved to be a difficult task for ensemble-level techniques because of the inherent heterogeneity of the species involved. Recently, however, a variety of techniques have been developed to detect and characterize molecular interactions at the level of single molecules [8] [9] [10] [11] [12] . We have applied two forms of these techniques to investigate the aggregation and fibril disaggregation processes of the Alzheimer's disease-associated peptide, amyloid-β 1−40 and its interactions with clusterin, an extracellular chaperone protein that is colocalized with senile amyloid plaques and has recently been genetically associated with Alzheimer's disease [13] [14] [15] [16] .
The single-molecule techniques that we have used are able to detect and characterize the ensemble of oligomeric species formed during the self-assembly and disassembly processes of Aβ 1−40 and that are implicated in the toxicity associated with Alzheimer's disease 1, 5, 6, 17 . The first of these techniques, confocal two-color coincidence detection (cTCCD), uses two spatially overlapped Gaussian laser beams that are combined to create a single confocal volume. cTCCD identifies multimolecular species having two different types of fluorophores through the observation of coincident bursts of fluorescence when they pass through this confocal volume, thus enabling oligomeric species to be detected and analyzed 8, 10 . The number of peptide molecules present in each oligomer, denoted the oligomer size, can be measured by comparing the fluorescence brightness values of the coincident fluorescence bursts with the brightness values of noncoincident (monomeric) bursts. This method is based on the principle that oligomers contain a greater number of molecules, and hence fluorophores, than monomers and will therefore emit proportionally brighter bursts. In this work, we refer to this metric as the 'apparent size' of an oligomer, as it is determined indirectly from the fluorescence intensity of the species (see Methods, Supplementary Methods and Supplementary Figs. 1−3 for details).
The second technique is a two-color version of total internal reflection fluorescence microscopy (TIRFM), an imaging technique that uses two overlapped lasers of different wavelengths to create dual excitation within the imaging field. Species having different fluorophores that are deposited onto a surface within this field can be imaged, and the distribution of colocalization of fluorescence can be analyzed to give images with detailed information about the composition, size and morphology of the species present (see Methods, Supplementary Fig. 1 and Supplementary Methods for details of data acquisition and instrumentation).
In this study, we have combined solution-phase detection by cTCCD with imaging of surface-bound species by TIRFM in order to gain insight not only into the aggregation process of Aβ 1−40 but also into the interactions between the Alzheimer's disease-linked extracellular chaperone clusterin and the various species populated along the Aβ 1−40 aggregation pathway.
8 0 VOLUME 19 NUMBER 1 JANUARY 2012 nature structural & molecular biology a r t i c l e s clusterin. To study the aggregation process, we labeled equimolar quantities of the Aβ 1−40 peptide with either the HiLyteFluor488 fluorophore or the HiLyteFluor647 fluorophore (Anaspec). We then mixed them, and incubated the sample at pH 7.4 and 37 °C. cTCCD measurements were made every 2 to 3 h as the peptides aggregated and eventually formed amyloid fibrils (Fig. 1a) . A series of control experiments revealed that the presence of either fluorophore had no appreciable effect on the bulk aggregation behavior of Aβ 1−40 , a result that is consistent with other studies using the same fluorescent peptides [18] [19] [20] [21] (Supplementary Fig. 2) . Analysis of the distribution of oligomers revealed a variety of soluble species, the majority of which were stable for over three hours at the concentrations and temperature required for cTCCD characterization (~25−50 pM and 21 °C).
In addition, control experiments demonstrated that this technique is capable of detecting even small quantities of aggregates and that the species present after dilution to picomolar sample concentrations are highly representative of those present at the higher concentrations under which aggregation readily takes place (600 nM-2 µM) (see Supplementary Discussion and Supplementary Fig. 3a,b) .
We first carried out aggregation experiments at a concentration of Aβ 1−40 of 30 nM, a value similar to its typical physiological concentration in cerebrospinal fluid 22 . We observed the formation of 300 pM of oligomers, representing approximately 1% of the total number of molecules present. This result confirms previous speculation that oligomeric species can form at Aβ 1−40 concentrations similar to those in physiological environments but at which fibril formation can be very slow 23 . In order to be able to collect data under concentrations where aggregation occurs more rapidly and where it is possible to conduct both bulk experiments and single-molecule measurements with high signal-to-noise ratios, we increased the concentrations to 600 nM or 2 µM for further experiments; these experimental conditions were also selected because they yielded highly reproducible data. The aggregation experiments at these higher concentrations revealed a rise in the population of stable oligomeric species to a peak concentration of ~20 nM during the incubation of 2 µM Aβ 1−40 (again representing about 1% of the total molecules) present along with a 75% decrease in the monomer concentration during the growth phase of fibril formation (Fig. 1a) .
The relative quantities of the different oligomeric forms that could be observed decreased exponentially with increasing apparent size under all conditions examined in this study (dimers were most abundant; the probability of finding a 10-mer relative to a dimer is ~3,000:1). Indeed, this distribution of apparent sizes was sustained throughout the progress of the aggregation reaction, suggesting that many intermediate species are involved in the growth of amyloid fibrils ( Fig. 1b and Supplementary Fig. 3c−e) . At these higher concentrations, we observed that the distribution of stable oligomer sizes is effectively the same as that formed at a concentration of 30 nM (Fig. 1c) . This exponential form of the distribution of apparent oligomer sizes directly observed in our experiments has been predicted by theoretical analysis of the aggregation of other protein systems, and it is consistent with models of both the bulk kinetics and the molecular processes of amyloid growth 7, 24 .
Characterizing the disaggregation of Ab 1−40 fibrils
We then set out to study the species present during the process that is the reverse of aggregation into fibrils, namely their disaggregation). Aβ 1−40 fibrils were formed from monomeric peptides at a concentration of 8 µM, pelleted by centrifugation, washed and finally resuspended in buffer in the absence of any additional Aβ 1−40 . Using TCCD, we monitored the release of soluble species into the buffer from the fibrils which was found to occur at a rate of (9.3 ± 3.1) × 10 −5 s −1 (rate is defined as particles (monomers or oligomers) per second, n = 12, s.e.m.) ( Fig. 1d; see Supplementary Methods for details). These results are similar to previous observations of exchange between amyloid fibrils and soluble proteins 25, 26 . However, the single-molecule experiments in the present study additionally reveal that the species released include a small population of stable oligomers as well as monomeric species (Fig. 1c) .
After 50 h of disaggregation, the concentrations of the various species in solution were constant and we assumed that the system had reached equilibrium. We then derived the thermodynamic stabilities of the various species present. The values of ∆G° were −18.2 ± 0.5 kJ mol −1 for dimers and an average of −38.9 ± 2.7 kJ mol −1 for the larger oligomers (error values are s.d.). These values are in good agreement with previous bulk measurements of the free energy of the formation of amyloid fibrils (−36 kJ mol −1 ) 27 . They also indicate that the dimers are inherently less a r t i c l e s thermodynamically stable than all larger oligomers and that the stability of the larger oligomers is mainly independent of their size ( Table 1) , findings that are consistent with previous computational analyses 28 .
Effect of clusterin on the aggregation of Ab 1−40
The observation of stable distributions of oligomers by cTCCD during the aggregation and disaggregation processes of Aβ 1−40 provided a framework for the investigation of the interactions between clusterin and such ensembles of species. In a series of experiments, we first used unlabeled clusterin to explore any changes in the Aβ 1−40 oligomer distribution resulting from the presence of the chaperone, and then we used AlexaFluor647-labeled clusterin to characterize the specific interactions between clusterin molecules and Aβ 1−40 species.
Control experiments confirmed that AlexaFluor647-labeled clusterin behaved in a similar manner to its unlabeled counterpart, which indicates that fluorescent labeling had no marked effect on the properties of clusterin studied in this work (Supplementary Fig. 4a ).
Addition of equimolar quantities of clusterin to monomeric Aβ 1−40 before the start of the aggregation reaction substantially inhibited the appearance of small oligomeric species, a finding that is consistent with bulk measurements showing that clusterin strongly inhibits fibril formation (Fig. 2a) 29, 30 . Moreover, when we added clusterin to solutions in which aggregation had progressed to a stage where a substantial population of oligomers was present, further self-association of the peptides was halted (Fig. 2b) . Throughout the reaction, the fraction of Aβ 1−40 peptides in oligomers corresponded well to the fraction of Aβ 1−40 peptides in clusterin-Aβ complexes, indicating that even in the presence of an excess of monomeric Aβ, it is the oligomeric fraction of the Aβ species that binds to clusterin (Fig. 2c) . These clusterin-Aβ complexes are very long-lived, persisting for over 50 h after dilution to nanomolar concentrations (Fig. 2d) . The binding between clusterin and Aβ oligomers was observed not only at concentrations of 2 µM but also at concentrations of 100 nM, conditions under which fibrils were not observed to form for days. The clusterin-Aβ complexes formed at these low concentrations were found to persist, after dilution, at picomolar concentrations for over 200 h ( Supplementary Fig. 4b−d) . Furthermore, the distribution of the sizes of the Aβ 1−40 oligomers observed in our experiments was not substantially altered in the presence of clusterin ( Fig. 3a and Supplementary  Fig. 4c ). We therefore conclude that the growth of larger aggregates, and ultimately amyloid fibrils, is inhibited as a result of the very effective sequestration of Aβ oligomers by clusterin molecules. 
a r t i c l e s

Effect of clusterin on the disaggregation of Ab 1−40 fibrils
Our studies of Aβ 1−40 fibril disaggregation in the presence of clusterin reveal that oligomers released from the fibrils bind to clusterin molecules, resulting in an increase in the total oligomer population compared to that observed in the absence of clusterin (Fig. 3b) . Our observation of a population of oligomers resulting from fibril disaggregation is consistent with the oligomeric 'halos' found around Aβ plaques in a mouse model of Alzheimer's disease 31 . Our result is also in line with studies suggesting clusterin increases the observable oligomer population, perhaps because of stabilization of Aβ oligomers by clusterin 32 . As found under aggregation conditions, the complexes between clusterin and the Aβ oligomers observed during disaggregation are very long-lived, persisting at nanomolar concentrations for over 50 h (Fig. 2d) . In each of these complexes, the ratio of clusterin:Aβ had a median value of 1.2 ± 1.1 (interquartile range), suggesting that there is a direct correlation between the number of clusterin molecules and the number of Aβ peptides present in a complex (Supplementary Fig. 5 ). In addition, the presence of clusterin bound to the Aβ fibrils was found to decrease both the rate and the extent of fibril disaggregation by inhibiting dissociation into monomers (the rate changes from (9.3 ± 3.1) × 10 −5 s −1 , n = 12, s.e.m., without clusterin to (17 ± 2.7) × 10 −6 s −1 , n = 8, s.e.m., with clusterin) (Fig. 3b,c and Supplementary Fig. 6 ). Similar binding of chaperones to fibrils and inhibition of their disaggregation has been observed in experiments with other systems [33] [34] [35] . The relative change in monomer and oligomer populations in our study was reflected in an increase in the magnitude of the free energies of formation of dimers (from −18.2 ± 0.5 kJ mol −1 to −25.8 ± 2.6 kJ mol −1 , both s.d.) and of larger oligomers (from −38.9 ± 2.7 kJ mol −1 to −43.9 ± 1.0 kJ mol −1 , both s.d.) when clusterin was present ( Table 1) . In all aggregation and disaggregation experiments, regardless of the presence or absence of clusterin, the distributions of oligomeric species showed an approximately exponential decrease in population with increasing apparent size (Fig. 3a) . Our single-molecule studies show that the extracellular chaperone clusterin binds to all members of the ensemble of soluble oligomers found to be present during the aggregation and disaggregation of Aβ 1−40 in our experiments. In this way, clusterin is able to prevent further growth and proliferation of aggregated species, and in vivo, it is likely to sequester the potentially toxic oligomeric species until they can be processed and degraded 38, 41, 42 . The methodology described in this study should be readily applicable to many different aggregation conditions and to a wide range of disease-associated peptides and proteins, and it therefore represents a powerful means of investigating, at the level of individual molecules, the seminal link between protein misfolding, aggregation and disease 1 .
DISCUSSION
In the particular case of the Aβ peptide discussed in this work, the ability of clusterin to sequester misfolded and potentially toxic oligomers provides a molecular basis for the recently identified genetic association between clusterin and Alzheimer's disease 13, 14 . Indeed, any perturbations that result in reduced clusterin levels, or in a reduction in the ability of clusterin to form stable and long-lived complexes with Aβ oligomers, are likely to increase susceptibility to Alzheimer's disease 13, 14 .
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. 
ONLINE METhODS
Confocal two-color coincidence detection instrumentation. The instrumentation used in this study has been previously described 10 . Gaussian laser beams of two colors (a tuned diode laser emitting at 488 nm (Spectra Physics, Cyan CDRH) and a helium-neon laser emitting at 633 nm (Melles Griot, 25LHP151) were overlapped and directed into a confocal microscope (Nikon Eclipse TE2000-U) to achieve dual-excitation in the confocal volume. The beams then passed through an oil-immersion objective (Appochromat 60×, NA 1.40, Nikon) and into the sample, with a final beam diameter of approximately 260 nm. The laser powers used were 60 ± 5 µW for the 633 nm laser and 50 ± 5 µW for the 488 nm laser and are low enough that photobleaching of the fluorophores during their time in the probe volume was not appreciable 8 . During measurements, 200 µL of the sample was placed on a 1 × 1 cm area of a BSA-coated glass coverslip (VWR, 631-1339). Then, the beam was focused on a confocal plane that was 10 µm into the measurement solution, above the coverslip surface. The fluorescence photons emitted from the sample were collected through the objective, passed through a 50-µm pinhole (Melles Griot), separated into the two different detection channels (dichroic 585DRLP Omega Filters) and directed to separate avalanche photodiode detectors (APDs) (SPCM-AQR-14, PerkinElmer Optoelectronics). The APDs fed photon count data in 1-ms bins into multichannel scalar cards on a personal computer (MCS-PCS, Ortec) which were saved for analysis in 600−800 8,000-ms frame units. During each measurement, the microscope stage was scanned using two orthogonal DC motors (M-112.1DG, Physik Instrumente) across the confocal volume at a constant rate of 200 µm s −1 . See Supplementary Methods for further instrumentation details.
Total internal reflection fluorescence microscopy instrumentation. Imaging was done using TIRFM, which aligns the outputs from a HeNe laser operating at 633 nm (25LHP991230, Melles Griot) and a diode laser operating at 488 nm (PC13589, Spectra Physics) and directs them down the edge of a TIRF objective (60× Plan Apo TIRF, NA 1.45, Nikon) mounted on a Nikon TE200 microscope. Fluorescence collected by the same objective was separated from the returning TIR beam by a dichroic (FF500646, Laser2000), split into blue and red components (585 DXLR, Omega Optical) and filtered using Dual-View (Optical Insights) mounted filters. The images were simultaneously recorded on an EMCCD (Cascade II: 512, Princeton instruments), whereby the EMCCD was split so that each color was recorded on one half of the EMCCD, at −70 °C. Data were acquired at 7.9 frames s −1 using Metamorph (Molecular Devices). See Supplementary Methods for further instrumentation details. Ab peptide preparation. Monomeric solutions of HiLyteFluor488 and HiLyteFluor647-labeled Aβ 1−40 (Anaspec) were prepared by dissolving the lyophilized peptide in NaOH, pH 12, followed by sonication over ice for 30 min (Bandelin Sonorex) and subsequent flash freezing into aliquots 43 . Prior to each of the incubations, aliquots of each peptide were brought to pH 7.4 by diluting into SSPE buffer (150 mM NaCl, 10 mM Na 2 H 2 PO 4 × H 2 O, 10 mM Na 2 EDTA, pH 7.4) to the desired aggregation reaction concentration and placed under relevant conditions (for example, 37 °C with agitation). The concentration for each labeled peptide was measured before mixing, using cTCCD.
Preparation and labeling of clusterin. Clusterin was extracted from human serum obtained from Wollongong Hospital, as described previously 44 , and labeled using the AlexaFluor647 dye with a maleimide linker (Invitrogen). See Supplementary Methods for details. cTCCD and TIRFM data acquisition. For the aggregation experiments, Aβ 1−40 (30 nM to 2 µM) was incubated in SSPE buffer (defined above) at 37 °C with agitation (2g on a rotary shaker). Samples were taken every 2 to 3 h and analyzed using cTCCD. For experiments with clusterin, the chaperone was added at a 1:1 molar ratio.
For disaggregation experiments, Aβ 1−40 fibrils were first prepared by quiescent aggregation of a solution of Aβ 1−40 at a concentration of 8 µM for 72 h at 37 °C. Pelleting and washing were carried out by centrifugation at ~10,000g for 30 min, followed by two identical washing steps involving resuspension of the pellet in SSPE buffer and additional centrifugation at ~10,000g for 2 min; finally, the pellet was resuspended in SSPE buffer. The soluble species in the solution were monitored and analyzed using cTCCD. For experiments with chaperones, clusterin and Aβ fibrils were incubated together for 12 to 16 h at 21 °C, and any clusterin that was not bound to fibrils was removed by centrifugation (leaving 100−200 nM clusterin bound to fibrils). See Supplementary Methods for details.
Quantification of oligomer distributions. The extent of oligomerization of a given sample was tracked by separating bursts coincident in both blue and red detection channels from non-coincident bursts. Quantification of oligomer distributions for cTCCD measurements was carried out by analyzing the brightness of the coincident oligomeric bursts. The brightness in the blue (488 nm) detection channel was corrected to account for changes in emission due to fluorescence resonance energy transfer (FRET) between the HiLyteFluor488-labeled and HiLyteFluor647-labeled peptides within an oligomer (see Supplementary Methods for details). Then the FRET-corrected blue channel brightness was scaled by the average burst brightness for a blue monomer to yield an average number of blue Aβ molecules in each oligomer. These data were then scaled by a factor of two to account for the fact that the blue-labeled peptides made up only half of the molecules in the aggregating solutions, to find the apparent size. Uncertainties in the measurement of this quantity arise from factors that include the Gaussian nature of the probevolume illumination, corrections for the error associated with assuming oligomers have equal numbers of red and blue peptides, as well as the inherent variation in the number of photons emitted by a single fluorophore. Both Aβ oligomers and clusterin-Aβ complexes were treated similarly with respect to the effects of FRET.
Statistical analysis. Statistical tests were carried out to determine the significance of changes in distributions of the apparent sizes of oligomers as well as the persistence of oligomeric species. In order to compare two values, two-sample, two-tailed, independent t-tests were used. For comparing multiple values, analysis of variance (ANOVA) one-factor tests were used. 
